News

Check back regularly for news and updates from SMFM.

Coding : Coding Tips Coding : Coding White Papers Press Publications & Guidelines Publications & Guidelines : Administrative Publications & Guidelines : Consult Series Publications & Guidelines : Endorsed Partner Pub Publications & Guidelines : Health Policy Publication Publications & Guidelines : Joint Publication Publications & Guidelines : Obstetric Care Consensus Publications & Guidelines : Public/Global Health Publications & Guidelines : SMFM Special Report Publications & Guidelines : SMFM Statement

SMFM Consult Series #42, The role of ultrasound in women who undergo cell-free DNA screening
SMFM Consult Series #42, The role of ultrasound in women who undergo cell-free DNA screening

The introduction of cell-free DNA screening for aneuploidy into obstetric practice in 2011 revolutionized the strategies utilized for prenatal testing. The purpose of this document is to review the current data on the role of ultrasound in women who have undergone or are considering cell-free DNA... Continue Reading

Date posted12/20/2017


SMFM Statement: Prenatal acetaminophen and outcomes in children
SMFM Statement: Prenatal acetaminophen and outcomes in children

Acetaminophen is the most widely used medicine during pregnancy. While the rate of use in pregnancy is difficult to determine because it is an over-the-counter medication, large surveys have reported that 40–65% of pregnant women use acetaminophen at some time during their pregnancy. The... Continue Reading

Date posted12/18/2017


Fetal Laser and Surgery
Fetal Laser and Surgery

Twin to twin transfusion syndrome (TTTS) is one of the most challenging clinical problems in monochorionic multifetal gestations with mortality rates as high as 80% if left untreated. Fetoscopic laser photocoagulation is described as the preferred method of treatment for select or severe cases of... Continue Reading

Date posted11/9/2017


Billing of 76801 and/or 76813 with cfDNA screening
Billing of 76801 and/or 76813 with cfDNA screening

Cell-free fetal DNA (cfDNA) screening has enhanced the ability to offer early aneuploidy screeningin pregnancy. The purpose of this White Paper is to describe billing recommendations when cfDNAscreening is done or considered in conjunction with first trimester Nuchal Translucency screening(CPT... Continue Reading

Date posted11/9/2017


ICD-10-CM Changes for 2018
ICD-10-CM Changes for 2018

SMFM Coding CommitteeNewsletter Coding Tip – August 2017ICD-10-CM Changes for 2018With the adoption of the International Classification of Diseases, 10th edition, Clinical Modification (ICD-10-CM), Maternal Fetal Medicine (MFM) specialists lost the opportunity to be specific in assigning... Continue Reading

Date posted08/31/2017


When and how are Ductus Venosus, Ductus Arteriosus and PR Intervals reported?
When and how are Ductus Venosus, Ductus Arteriosus and PR Intervals reported?

The SMFM Coding Committee frequently receives inquiries on when and how to bill for Doppler of the ductus venosus, Doppler of the ductus arteriosus, and PR Interval measurement. Below are the suggested ways to report these services: Ductus venosus Doppler: This is billable when sampled as part of... Continue Reading

Date posted07/20/2017


Reporting Complications in Pregnancy When No Specific Codes Exists
Reporting Complications in Pregnancy When No Specific Codes Exists

One challenge for ICD-10-CM code selection for MFM is the presentation of symptoms or conditions for which a precise diagnosis code doesn’t exist. ICD-10-CM offers several categories and subcategories from which to choose. They are: O09.89- Supervision of other high risk... Continue Reading

Date posted12/1/2016


Perinatal Telemedicine
Perinatal Telemedicine

Telemedicine is the delivery of medical care or services from a distant site. Telemedicine provides two-way, communication between a patient and healthcare provider at a distant site. The communication is supported by audio and video equipment that allows a physician at the main hospital/office to... Continue Reading

Date posted10/31/2016


Comparing variation in hospital rates of cesarean delivery among low risk women using 3 measures
Comparing variation in hospital rates of cesarean delivery among low risk women using 3 measures

This report describes the development of a measure of low-risk cesarean delivery by the Society for Maternal-Fetal Medicine (SMFM). Safely lowering the cesarean delivery rate is a priority for maternity care clinicians and health care delivery systems. Therefore, hospital quality assurance... Continue Reading

Date posted10/1/2016


SMFM Consult Series #41: The use of chromosomal microarray for prenatal diagnosis
SMFM Consult Series #41: The use of chromosomal microarray for prenatal diagnosis

Chromosomal microarray analysis is a high-resolution, whole-genome technique used to identifychromosomal abnormalities, including those detected by conventional cytogenetic techniques, aswell as small submicroscopic deletions and duplications referred to as copy number variants. Becausechromosomal... Continue Reading

Date posted09/1/2016


SMFM Consult Series#39: Diagnosis and antenatal management of congenital cytomegalovirus infection
SMFM Consult Series#39: Diagnosis and antenatal management of congenital cytomegalovirus infection

Diagnosis/definition: Primary Infection: After suspicious ultrasonographic findings (e.g echogenic bowel, cerebral ventriculomegaly and calcifications, and IUGR)- testing for maternal CMV infection For women suspected of having primary CMV infection in pregnancy, diagnosis should be either... Continue Reading

Date posted05/1/2016


Amniotic fluid embolism: diagnosis and management
Amniotic fluid embolism: diagnosis and management

Diagnosis/definition: Triad of sudden hypoxia and hypotension, followed in many cases by coagulopathy, all occurring in relation to labor and delivery DDX in any women with sudden cardiovascular collapse or cardiac arrest seizures, severe respiratory difficulty or hypoxia, particularly if... Continue Reading

Date posted04/1/2016